KAM
LLY icon

Knightsbridge Asset Management’s Eli Lilly LLY Stock Holding History

Knightsbridge Asset Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Buy
1,792
+189
+12% +$192K 0.22% 61
2025
Q4 		$1.72M Buy
1,603
+49
+3% +$46.9K 0.28% 61
2025
Q3 		$1.19M Buy
1,554
+77
+5% +$57.3K 0.2% 67
2025
Q2 		$1.15M Buy
1,477
+579
+64% +$450K 0.25% 61
2025
Q1 		$741K Buy
898
+85
+10% +$70.7K 0.19% 68
2024
Q4 		$628K Buy
813
+15
+2% +$12.4K 0.15% 82
2024
Q3 		$707K Buy
798
+98
+14% +$88.1K 0.16% 70
2024
Q2 		$634K Buy
700
+4
+0.6% +$3.2K 0.16% 67
2024
Q1 		$406K Hold
696
– – 0.11% 83
2023
Q4 		$406K Sell
696
-22
-3% -$12.8K 0.11% 83
2023
Q3 		$386K Buy
718
+24
+3% +$12.4K 0.12% 84
2023
Q2 		$326K Sell
694
-693
-50% -$291K 0.1% 88
2023
Q1 		$477K Buy
1,387
+308
+29% +$104K 0.08% 97
2022
Q4 		$395K Buy
1,079
+282
+35% +$100K 0.07% 105
2022
Q3 		$258K Buy
+797
New +$253K 0.05% 99

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Knightsbridge Asset Management's LLY Position: Q1 2026 in Review

Knightsbridge Asset Management increased its Eli Lilly (LLY) stake by 12% in Q1 2026, buying an estimated $192K and bringing the position to 1,792 shares worth $1.65M. The position accounts for 0.22% of the portfolio, ranked #61.

Knightsbridge Asset Management first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.72M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Knightsbridge Asset Management held 1,792 shares of Eli Lilly worth $1.65M as of Q1 2026.
  • Knightsbridge Asset Management bought 189 Eli Lilly shares in Q1 2026, an estimated $192K.
  • Eli Lilly made up 0.22% of Knightsbridge Asset Management's portfolio in Q1 2026, its #61 holding.
  • Knightsbridge Asset Management first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Knightsbridge Asset Management's Eli Lilly position peaked at $1.72M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Knightsbridge Asset Management's 13F filing for Q1 2026, filed 15 May 2026.